Optometrists and general ophthalmologists field a significant number of geographic atrophy (GA) patients. To ensure patients are promptly referred to retina specialists, Dr. Rahimy will highlight the risk factors that drive this disease, imaging modalities that are best suited for GA evaluation, the type of lesion patterns that place patients at high risk for progression, and potential treatments.
This activity is supported by an unrestricted medical educational grant from Apellis.
Upon completion of this activity, the participant should be able to:
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
This activity, COPE Activity Number 124039, is accredited by COPE for continuing education for optometrists for 1.5 hours.
Course #: 78598-TD
Activity #: 124039
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Provided by Evolve Medical Education 
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Ehsan Rahimy, MD
Palo Alto Medical Foundation
Palo Alto, CA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Ehsan Rahimy, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Apellis, Genentech, Google, and Regeneron Pharmaceuticals. Speaker’s List: Allergan and Regeneron Pharmaceuticals.
The Evolve staff and planners have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Apellis.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
